$PFE Headlines ’Tis the season for buying st
Post# of 44845
Posted On: 12/26/2014 12:55:21 PM
$PFE Headlines
’Tis the season for buying stocks dumped for tax reasons 9:16 a.m. Dec. 24, 2014 - Michael Brush
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
What I learned with my 10 stock recommendations a year ago 6:00 a.m. Dec. 23, 2014 - Diana Furchtgott-Roth
How to find ‘winners’ among the worst S&P 500 stocks 5:22 p.m. Dec. 22, 2014 - Philip van Doorn
Stocking stuffers 12:27 p.m. Dec. 17, 2014 - Mark Hulbert
Boeing’s shares get lift from dividend hike, buyback 7:23 p.m. Dec. 15, 2014 - MarketWatch
U.S. stocks end choppy session lower 4:44 p.m. Dec. 15, 2014 - Barbara Kollmeyer
Pfizer, OPKO Health partner on growth-hormone treatment 1:50 p.m. Dec. 15, 2014 - Angela Chen
Opko Health's stock soars after Pfizer development agreement 8:15 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko's stock jumps 8.8% premarket after Pfizer development agreement 8:07 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko Health, Pfizer team up to develop Opko's GHD treatment 8:06 a.m. Dec. 15, 2014 - Tomi Kilgore
Drug makers face another $65 billion patent cliff 12:41 p.m. Dec. 10, 2014 - Russ Britt
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
Visa, Goldman Sachs powering Dow to 18,000 4:29 p.m. Dec. 5, 2014 - Tomi Kilgore
Will Santa come to Broad and Wall? 1:54 p.m. Dec. 1, 2014 - The Trading Deck
Dow buy signals push index higher 11:39 a.m. Nov. 24, 2014 - The Trading Deck
Are consumers getting gouged on health care? 9:35 a.m. Nov. 22, 2014 - Russ Britt
AstraZeneca advances in London; pound rises as inflation ticks up 11:59 a.m. Nov. 18, 2014 - Carla Mozee
Zoetis unveils $500 million buyback plan 7:52 a.m. Nov. 18, 2014 - Michael Calia
AstraZeneca forecasts revenue of $45 bln by 2023 2:42 a.m. Nov. 18, 2014 - MarketWatch.com
Drug Prices, M&A Top the Agenda for ’15 7:44 p.m. Dec. 25, 2014 - The Wall Street Journal Interactive Edition
Endo and BioDelivery Sciences submit NDA for transmucosal pain med 12:41 p.m. Dec. 25, 2014 - Seeking Alpha
Pfizer's Immunology Pipeline Has Few Bright Spots Besides Xeljanz 10:21 a.m. Dec. 24, 2014 - Seeking Alpha
Microsoft, Google Lead Tech Firms With The Most Cash 1:29 p.m. Dec. 23, 2014 - Investors Business Daily
Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical 12:45 p.m. Dec. 23, 2014 - Seeking Alpha
Broker Darlings Of The Dow: Pfizer Ranks As A Top 15 Analyst Pick 12:21 p.m. Dec. 23, 2014 - TheStreet.com
Great Dividends: Meet the Preliminary 2015 Dogs of the Dow 10:47 a.m. Dec. 23, 2014 - 247WallSt.com
PTC Therapeutics begins rolling NDA for DMD 10:20 a.m. Dec. 23, 2014 - Seeking Alpha
3 Best Dividend ETFs for 2015 6:19 a.m. Dec. 23, 2014 - InvestorPlace.com
Corporate Watch: News Digest 12:06 a.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
It's Official: Zoetis Belongs In Your Dividend Growth Portfolio 4:46 p.m. Dec. 22, 2014 - Seeking Alpha
FTC Puts Conditions on Lilly’s Deal to Buy Novartis Unit 12:46 p.m. Dec. 22, 2014 - The Wall Street Journal Interactive Edition
Wall Street Breakfast: China Offers Support For Russia's Currency Crisis 6:29 a.m. Dec. 22, 2014 - Seeking Alpha
Dow Stars, Biotech Lead 13 Dividend Stocks Increasing Payouts 5:13 a.m. Dec. 22, 2014 - InvestorPlace.com
Update: In A Surprise Twist, AstraZeneca Wins Accelerated FDA Approval For Lynparza 4:32 p.m. Dec. 21, 2014 - Seeking Alpha
Update: Ligand Wins EU Approval For Duavive 10:02 a.m. Dec. 21, 2014 - Seeking Alpha
New Pfizer bid unlikely says AstraZeneca CEO 7:09 a.m. Dec. 21, 2014 - Seeking Alpha
Holiday Hikes 10:33 p.m. Dec. 19, 2014 - Barrons.com
7 Stocks Providing Their Shareholders A Growing Income With Higher Cash Dividends 10:11 p.m. Dec. 19, 2014 - Seeking Alpha
United Therapeutics Lung Drug Keeps Going And Going 4:20 p.m. Dec. 19, 2014 - Investors Business Daily
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cintas, Deere, Thermo Fisher and Pfizer 9:10 a.m. Dec. 19, 2014 - PR Newswire - PRF
Pan American Fertilizer (TSX.V: PFE, Frankfurt: 6GF) Provides an Update on its Operations and Audit Filings and Announces Transfer to NEX 12:48 p.m. Dec. 18, 2014 - ACCESSWIRE
Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia 8:00 a.m. Dec. 18, 2014 - BusinessWire - BZX
Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy 8:01 a.m. Dec. 17, 2014 - BusinessWire - BZX
Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts 10:00 a.m. Dec. 16, 2014 - BusinessWire - BZX
Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis 8:02 a.m. Dec. 16, 2014 - BusinessWire - BZX
Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology 6:30 p.m. Dec. 15, 2014 - BusinessWire - BZX
Pfizer Declares First-Quarter 2015 Dividend 12:06 p.m. Dec. 15, 2014 - BusinessWire - BZX
InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton 9:31 a.m. Dec. 15, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause 9:02 a.m. Dec. 10, 2014 - BusinessWire - BZX
Robbins Geller Rudman & Dowd LLP Announces Pendency of Pfizer Inc. Securities Class Action 11:00 a.m. Dec. 9, 2014 - BusinessWire - BZX
New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers 10:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc. 8:06 a.m. Dec. 8, 2014 - PR Newswire - PRF
Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform 8:02 a.m. Dec. 8, 2014 - BusinessWire - BZX
iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets 2:30 a.m. Dec. 8, 2014 - PR Newswire - PRF
Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors 4:00 p.m. Dec. 4, 2014 - BusinessWire - BZX
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative 11:29 a.m. Dec. 4, 2014 - PR Newswire - PRF
’Tis the season for buying stocks dumped for tax reasons 9:16 a.m. Dec. 24, 2014 - Michael Brush
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
What I learned with my 10 stock recommendations a year ago 6:00 a.m. Dec. 23, 2014 - Diana Furchtgott-Roth
How to find ‘winners’ among the worst S&P 500 stocks 5:22 p.m. Dec. 22, 2014 - Philip van Doorn
Stocking stuffers 12:27 p.m. Dec. 17, 2014 - Mark Hulbert
Boeing’s shares get lift from dividend hike, buyback 7:23 p.m. Dec. 15, 2014 - MarketWatch
U.S. stocks end choppy session lower 4:44 p.m. Dec. 15, 2014 - Barbara Kollmeyer
Pfizer, OPKO Health partner on growth-hormone treatment 1:50 p.m. Dec. 15, 2014 - Angela Chen
Opko Health's stock soars after Pfizer development agreement 8:15 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko's stock jumps 8.8% premarket after Pfizer development agreement 8:07 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko Health, Pfizer team up to develop Opko's GHD treatment 8:06 a.m. Dec. 15, 2014 - Tomi Kilgore
Drug makers face another $65 billion patent cliff 12:41 p.m. Dec. 10, 2014 - Russ Britt
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
Visa, Goldman Sachs powering Dow to 18,000 4:29 p.m. Dec. 5, 2014 - Tomi Kilgore
Will Santa come to Broad and Wall? 1:54 p.m. Dec. 1, 2014 - The Trading Deck
Dow buy signals push index higher 11:39 a.m. Nov. 24, 2014 - The Trading Deck
Are consumers getting gouged on health care? 9:35 a.m. Nov. 22, 2014 - Russ Britt
AstraZeneca advances in London; pound rises as inflation ticks up 11:59 a.m. Nov. 18, 2014 - Carla Mozee
Zoetis unveils $500 million buyback plan 7:52 a.m. Nov. 18, 2014 - Michael Calia
AstraZeneca forecasts revenue of $45 bln by 2023 2:42 a.m. Nov. 18, 2014 - MarketWatch.com
Drug Prices, M&A Top the Agenda for ’15 7:44 p.m. Dec. 25, 2014 - The Wall Street Journal Interactive Edition
Endo and BioDelivery Sciences submit NDA for transmucosal pain med 12:41 p.m. Dec. 25, 2014 - Seeking Alpha
Pfizer's Immunology Pipeline Has Few Bright Spots Besides Xeljanz 10:21 a.m. Dec. 24, 2014 - Seeking Alpha
Microsoft, Google Lead Tech Firms With The Most Cash 1:29 p.m. Dec. 23, 2014 - Investors Business Daily
Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical 12:45 p.m. Dec. 23, 2014 - Seeking Alpha
Broker Darlings Of The Dow: Pfizer Ranks As A Top 15 Analyst Pick 12:21 p.m. Dec. 23, 2014 - TheStreet.com
Great Dividends: Meet the Preliminary 2015 Dogs of the Dow 10:47 a.m. Dec. 23, 2014 - 247WallSt.com
PTC Therapeutics begins rolling NDA for DMD 10:20 a.m. Dec. 23, 2014 - Seeking Alpha
3 Best Dividend ETFs for 2015 6:19 a.m. Dec. 23, 2014 - InvestorPlace.com
Corporate Watch: News Digest 12:06 a.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
It's Official: Zoetis Belongs In Your Dividend Growth Portfolio 4:46 p.m. Dec. 22, 2014 - Seeking Alpha
FTC Puts Conditions on Lilly’s Deal to Buy Novartis Unit 12:46 p.m. Dec. 22, 2014 - The Wall Street Journal Interactive Edition
Wall Street Breakfast: China Offers Support For Russia's Currency Crisis 6:29 a.m. Dec. 22, 2014 - Seeking Alpha
Dow Stars, Biotech Lead 13 Dividend Stocks Increasing Payouts 5:13 a.m. Dec. 22, 2014 - InvestorPlace.com
Update: In A Surprise Twist, AstraZeneca Wins Accelerated FDA Approval For Lynparza 4:32 p.m. Dec. 21, 2014 - Seeking Alpha
Update: Ligand Wins EU Approval For Duavive 10:02 a.m. Dec. 21, 2014 - Seeking Alpha
New Pfizer bid unlikely says AstraZeneca CEO 7:09 a.m. Dec. 21, 2014 - Seeking Alpha
Holiday Hikes 10:33 p.m. Dec. 19, 2014 - Barrons.com
7 Stocks Providing Their Shareholders A Growing Income With Higher Cash Dividends 10:11 p.m. Dec. 19, 2014 - Seeking Alpha
United Therapeutics Lung Drug Keeps Going And Going 4:20 p.m. Dec. 19, 2014 - Investors Business Daily
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cintas, Deere, Thermo Fisher and Pfizer 9:10 a.m. Dec. 19, 2014 - PR Newswire - PRF
Pan American Fertilizer (TSX.V: PFE, Frankfurt: 6GF) Provides an Update on its Operations and Audit Filings and Announces Transfer to NEX 12:48 p.m. Dec. 18, 2014 - ACCESSWIRE
Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia 8:00 a.m. Dec. 18, 2014 - BusinessWire - BZX
Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy 8:01 a.m. Dec. 17, 2014 - BusinessWire - BZX
Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts 10:00 a.m. Dec. 16, 2014 - BusinessWire - BZX
Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis 8:02 a.m. Dec. 16, 2014 - BusinessWire - BZX
Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology 6:30 p.m. Dec. 15, 2014 - BusinessWire - BZX
Pfizer Declares First-Quarter 2015 Dividend 12:06 p.m. Dec. 15, 2014 - BusinessWire - BZX
InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton 9:31 a.m. Dec. 15, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause 9:02 a.m. Dec. 10, 2014 - BusinessWire - BZX
Robbins Geller Rudman & Dowd LLP Announces Pendency of Pfizer Inc. Securities Class Action 11:00 a.m. Dec. 9, 2014 - BusinessWire - BZX
New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers 10:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc. 8:06 a.m. Dec. 8, 2014 - PR Newswire - PRF
Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform 8:02 a.m. Dec. 8, 2014 - BusinessWire - BZX
iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets 2:30 a.m. Dec. 8, 2014 - PR Newswire - PRF
Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors 4:00 p.m. Dec. 4, 2014 - BusinessWire - BZX
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative 11:29 a.m. Dec. 4, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼